D-1625-2020 Class III Terminated

Recalled by Arbor Pharmaceuticals Inc. — Atlanta, GA

FDA drug recall D-1625-2020 was initiated by Arbor Pharmaceuticals Inc. on Sep 16, 2020 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Feb 22, 2022). Affected quantity: 1846 cartons.

Recall details

Product Type
Drugs
Report Date
Oct 7, 2020
Initiation Date
Sep 16, 2020
Termination Date
Feb 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1846 cartons

Product description

Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the United States

Code information

Lot #: 356884 Exp. 11/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1625-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1625-2020. Report a data issue: hello@regdatalab.com.